Iradimed (IRMD) Research & Development (2013 - 2026)
Iradimed's (IRMD) quarterly Research & Development came in at $4.1 million in Q1 2026, down 2.97% year-on-year from $4.2 million in Q1 2025, and up 141.17% on a QoQ basis from -$9.8 million in Q4 2025.
Iradimed (IRMD) Research & Development (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has 14 years of Research & Development data on file, last reported at $4.1 million in Q1 2026.
- On a quarterly basis, Research & Development fell 2.97% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was -$4.2 million, a 122.34% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 80.95% from the prior year.
- Research & Development for Q1 2026 stood at $4.1 million, up from -$9.8 million in the prior quarter.
- Over the last five years, Research & Development for IRMD reached as high as $13.4 million in Q4 2024 and fell as low as -$9.8 million in Q4 2025.
- Historically, Research & Development has averaged $1.8 million across 5 years, with a median of $821000.0 in 2024.
- Across the five-year window, Research & Development surged 531.84% in 2022 and slumped 173.69% in 2025, its largest moves.
- Year by year, Research & Development stood at $3.7 million in 2022, then decreased by 9.16% to $3.3 million in 2023, then jumped by 301.13% to $13.4 million in 2024, then slumped by 173.69% to -$9.8 million in 2025, then surged by 141.17% to $4.1 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $4.1 million in Q1 2026, -$9.8 million in Q4 2025, and $674362.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iradimed | 1.20 Bn | 1.14 Bn | 16.81 Mn | 4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | -9.84 Mn |
| Sep 30, 2025 | 674,362.00 |
| Jun 30, 2025 | 877,362.00 |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 13.35 Mn |
| Sep 30, 2024 | 639,467.00 |
| Jun 30, 2024 | 801,129.00 |
| Mar 31, 2024 | 821,000.00 |
| Dec 31, 2023 | 3.33 Mn |
| Sep 30, 2023 | 452,555.00 |
| Jun 30, 2023 | 2.95 Mn |
| Mar 31, 2023 | 793,716.00 |
| Dec 31, 2022 | 3.67 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 662,599.00 |
| Mar 31, 2022 | 519,095.00 |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 480,696.00 |
| Jun 30, 2021 | 2.47 Mn |